| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Passage Bio, Inc. (PASG) has 4 insiders with recent SEC Form 4 filings, including 4 buys and 8 sells. PASG is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 6.07M | $33.91M | - | |
| 10% | 623.7K | $3.49M | - | |
| CEO | 10.6K | $59.3K | - | |
| CFO | 7.5K | $41.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2024 | Borthwick Kathleen62 | SVP, Interim CFO | Sale+OE | 10,672 | $0.91 | $9,711.52 | -29.2% | +52.0% | -7.9% | |
| Jan 2, 2024 | Cale Edgar B. | GC &Corporate Secretary | Sale+OE | 15,813 | $0.91 | $14,389.83 | -25.6% | +52.0% | -7.9% | |
| Jul 28, 2023 | King Simona | Chief Financial Officer | Sale+OE | 11,453 | $0.88 | $10,078.64 | -32.3% | -25.9% | +4.5% | |
| Jun 28, 2023 | Orbimed Advisors LLC67 | 10% Owner | Buy | 1,192,577 | $0.84 | $1,001,764.68 | +8.3% | -17.2% | +13.2% | |
| Jun 16, 2023 | Fotopoulos Alexandros | Chief Technical Officer | Sale+OE | 4,052 | $0.93 | $3,778.49 | -12.4% | -21.9% | +9.2% | |
| Apr 18, 2023 | King Simona | Chief Financial Officer | Sale+OE | 2,053 | $1.05 | $2,155.65 | -50.0% | -6.5% | +18.7% | |
| Dec 1, 2022 | Kapadia Sandip71 | Director | Sell | 5,000 | $1.19 | $5,964.50 | -100% | +8.4% | -43.9% | |
| Nov 22, 2022 | Fotopoulos Alexandros | Chief Technical Officer | Sale+OE | 3,720 | $1.33 | $4,947.60 | -15.5% | +0.8% | -48.9% | |
| Sep 19, 2022 | Toernsen Monika Maria | Chief Commercial Officer | Sale+OE | 1,681 | $1.51 | $2,539.15 | -33.6% | -26.7% | -55.7% | |
| May 4, 2022 | Orbimed Advisors LLC67 | 10% Owner | Buy | 525,000 | $1.94 | $1,016,285.00 | +4.1% | -17.0% | -53.4% |